Dr. Olivier Lucas

Associate Director, Diagnostic Testing Solutions - Oxford Nanopore Technologies

Olivier holds a PhD in Molecular Biology and did a postdoc in Molecular Medicine at the University of South Florida. Since then, he held different commercial roles in genomics companies and has been at Oxford Nanopore for 6 years. He is now the associate director for Oncology at Oxford Nanopore Diagnostics with the aim to transform healthcare through real-time genomics.

The Most Comprehensive Insight in Cancer Genomes: New Discoveries

With the genetics behind cancer being both diverse and complex, there are many genomic deviations that need to be detected and analyzed to further our understanding of the disease. Using nanopore sequencing, scientists can achieve the most comprehensive insight into cancer genomes. To explore this further, this symposium will bring together experts in cancer research, where they’ll cover how they are using the technology.

The speakers will discuss detecting missing structural variants, characterizing mutation patterns and how nanopore sequencing has advanced their research.